Navigation Links
SENOMYX ANNOUNCES NESTLE'S SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
Date:5/5/2009

SAN DIEGO, CA, May 5, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Nestle SA has selected a new flavor ingredient, which was discovered under the companies' collaborative research and license agreement, for development activities and evaluation of commercial potential in the coffee and coffee whitener fields. In addition, Nestle is continuing to assess another ingredient for potential future selection in the same field. Both ingredients are undergoing development activities that include scale-up production and safety studies to support regulatory filings in the U.S. and elsewhere. Senomyx is working closely with Nestle regarding the testing of both ingredients in product prototypes covered under the agreement.

The selection of the new flavor ingredient marks the successful early conclusion of the discovery phase and the beginning of the development phase of the agreement with Nestle. Based on this progress, Senomyx received a milestone payment from Nestle and the collaborative agreement between the companies has been amended to provide for the research and development funding period to conclude in July 2010, one year earlier than previously anticipated. In addition, Nestle's funding obligations over the remaining collaborative period have been reduced to reflect a commensurate reduction in Senomyx's internal research and development resources dedicated to the Nestle project.

"Senomyx's new flavor ingredient has met Nestle's requirements for evaluation and initiation of development activities. We are very pleased to have accomplished this research goal and to begin focusing on the next phase of our collaboration," stated Kent
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
7. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
8. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
9. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
10. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCall...M ) today reported completion of patient enrollmen...tara® in patients with relapsed glioblastoma ...er. Cotara is a targeted monoclonal antibody link...l new treatment for GBM. Cotara specifically targ...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 ...leaders in technology development and product inte...announced the December 11th deadline for technolog...in its 14th year, TechConnect World, in associatio...NSTI), and the Clean Technology and Sustainable In...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-Asia/... "Company") (NYSE: SCR ), a leading pharmaceutic...cturing, and marketing of branded,generic and prop...that 105 of,its drugs have been included in China,... was issued by China,s Ministry of Human Resources...
(Date:12/2/2009)..., HOBOKEN, N.J., Dec. 2 Accordin...to 45 percent of Americans diagnosed with diabetes... Diabetic retinopathy, damage to the retina caused...ness in people with diabetes and is one of the mos...0 percent of all patients who,ve had diabetes for ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...T WAYNE, Ind., Aug. 7 The Alliance for Research i... 3rd annual international,conference will be held ...urdue University Fort Wayne (IPFW) campus., For o... web site, http://www.a4rimm.org/ , "This year,s ... the,Science of Healing," says Dr. Angela LaSalle,...
...KING RIDGE, N.J., Aug. 7 Heritage Labs, a,divisio...the Appraise(R) Home,A1c Kit, a new at-home consum... level of diabetics and potential diabetics. The A... inexpensive and easy-to-use blood test,that produ...valent to whole,blood tests collected in physician...
...ADENA, Calif., Aug. 7 AutoImmune Inc. (OTC,Pink S... or $0.01 per share,basic and diluted, for the thr... loss of $62,000, or break even per share basic an...7. For the six months ended June 30, 2008,the net ...luted, compared,with net loss of $54,000, or break...
Other Biology Technology:The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 3Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 4AutoImmune Inc. Reports 2008 Second Quarter Financial Results 2AutoImmune Inc. Reports 2008 Second Quarter Financial Results 3
(Date:12/4/2009)...tivity in organs relevant for coronary artery dise...rsity Karolinska Institutet have identified a modu...of white blood cells into the atherosclerotic plaq... open-access journal PLoS Genetics , suggest that...he development of atherosclerosis may help to redu...
(Date:12/4/2009)... of heart cells, University of Iowa investigators ...lmodulin kinase II (CaM kinase), disrupts the elec...hich also involved Columbia University, was publis...al Biology . , "Recently, researchers have deve...critical regulator of the heart,s response to inju...
(Date:12/3/2009)...ormation and adapt to changes in our daily environ...ars to lie in the minute junctions where nerve cel...ngone Medicine Center researchers. The study is pu... , The scientists, led by Wen-Biao Gan, PhD, ass... NYU School of Medicine, discovered that a delicat...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Sunlight May Cause Rash in Autoimmune Disease 53903 1Sunlight May Cause Rash in Autoimmune Disease 53903 2Vitamin Shoppe Industries Inc to Discuss Second Quarter 2009 for Bondholders 53899 1AMN Healthcare Announces Second Quarter 2009 Results 53895 1AMN Healthcare Announces Second Quarter 2009 Results 53895 2AMN Healthcare Announces Second Quarter 2009 Results 53895 3AMN Healthcare Announces Second Quarter 2009 Results 53895 4AMN Healthcare Announces Second Quarter 2009 Results 53895 5AMN Healthcare Announces Second Quarter 2009 Results 53895 6AMN Healthcare Announces Second Quarter 2009 Results 53895 7AMN Healthcare Announces Second Quarter 2009 Results 53895 8AMN Healthcare Announces Second Quarter 2009 Results 53895 9AMN Healthcare Announces Second Quarter 2009 Results 53895 10AMN Healthcare Announces Second Quarter 2009 Results 53895 11AMN Healthcare Announces Second Quarter 2009 Results 53895 12AMN Healthcare Announces Second Quarter 2009 Results 53895 13AMN Healthcare Announces Second Quarter 2009 Results 53895 14AMN Healthcare Announces Second Quarter 2009 Results 53895 15AMN Healthcare Announces Second Quarter 2009 Results 53895 16
... techniques have brought us the resurgence of Amer...the rescue of prized lobster fisheries. So how can...such failures, from the catastrophic loss of Guate...er salmon kill in 2006" , In this week,s special ...f Sciences (online), Indiana University political ...
...r odious? Is there something in the chemistry of a...erceive its smell? Scientists at the Weizmann Inst...at Berkeley have now discovered that there is, ind...ure of a substance can help predict whether we wil...ght and hearing, for instance, our perceptions are...
...produce cheap, sustainable solar energy by imitati...nia Institute of Technology professor Nate Lewis a...chitecture of grass and photosynthesis to capture ... at how Dr. Lewis and his CalTech research team ar...inexpensive everyday products like house paint and...
Other Biology News:Why conservation efforts often fail 2Sweet smell 2
COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Growth Hormone from Cell Sciences
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: